Cargando…
Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma
BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (Tg...
Autores principales: | Ausavarat, Surasawadee, Sriprapaporn, Jiraporn, Satayaban, Busara, Thongnoppakhun, Wanna, Laipiriyakun, Aunchalee, Amornkitticharoen, Boontham, Chanachai, Rujaporn, Pattanachak, Chaveevan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523908/ https://www.ncbi.nlm.nih.gov/pubmed/26244057 http://dx.doi.org/10.1186/s13044-015-0024-4 |
Ejemplares similares
-
Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022) -
Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid
por: Huang, Di, et al.
Publicado: (2017) -
Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid
por: Paek, Ki Young, et al.
Publicado: (2012) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021) -
Circulating thyrotropin is upregulated by estradiol
por: Benvenga, Salvatore, et al.
Publicado: (2018)